RSS-Feed abonnieren
PDF herunterladen
DOI: 10.1055/s-0041-1730847
Pandoraea apista Bacteremia in a COVID-Positive Man: A Rare Coinfection Case Report from North India
Abstract
Pandoraea apista is a novel gram-negative bacillus usually isolated from respiratory specimens of cystic fibrosis patients. Few cases of bacteremia have also been reported due to this rare pathogen. Emergence of multidrug-resistant isolates of this bacillus is of grave concern. Here, we report a very interesting and unusual case of Pandoraea apista bacteremia in a coronavirus disease (COVID)–positive elderly diabetic man suffering from pneumonia. Prompt isolation and antibiotic sensitivity testing guided the patient’s treatment and yielded favorable outcome. The need of automated methods for identification and sensitivity testing limits the reporting of this rare but important pathogen in hospital settings. Detailed research work and studies are needed in this direction to better understand this pathogen and its clinical manifestations for better patient outcome.
Publikationsverlauf
Artikel online veröffentlicht:
28. Juni 2021
© 2021. The Indian Association of Laboratory Physicians. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
-
References
- 1 Coenye T, Falsen E, Hoste B. et al. Description of Pandoraea gen. nov. with Pandorae aapista sp. nov., Pandoraea pulmonicola sp. nov., Pandoraea pnomenusa sp. nov., Pandoraea sputorum sp. nov. and Pandoraea norimbergensis comb. nov. Int J SystEvolMicrobiol 2000; 50 (02) 887-899
- 2 Ambrose M, Malley RC, Warren SJ. et al. Pandoraea pnomenusa isolated from an Australian patient with cystic fibrosis. Front Microbiol 2016; 7: 692
- 3 Jeong SE, Lee HJ, Jia B, Jeon CO. Pandoraea terrae sp. nov., isolated from forest soil, and emended description of the genus Pandoraea Coenye et al. 2000. Int J SystEvolMicrobiol 2016; 66 (09) 3524-3530
- 4 Feng Y, Ling Y, Bai T. et al. COVID-19 with different severities: a multicenter study of clinical features. Am J RespirCrit Care Med 2020; 201 (11) 1380-1388
- 5 Daneshvar MI, Hollis DG, Steigerwalt AG. et al. Assignment of CDC weak oxidizer group 2 (WO-2) to the genus Pandoraea and characterization of three new Pandoraea genomospecies. J ClinMicrobiol 2001; 39 (05) 1819-1826
- 6 Elborn JS. Cystic fibrosis. Lancet 2016; 388 (10059) 2519-2531
- 7 Aravena-Román M. Cellular fatty acid-deficient Pandoraea isolated from a patient with cystic fibrosis. J Med Microbiol 2008; 57 (Pt 2) 252
- 8 Stryjewski ME, LiPuma JJ, Messier Jr RH, Reller LB, Alexander BD. Sepsis, multiple organ failure, and death due to Pandoraea pnomenusa infection after lung transplantation. J ClinMicrobiol 2003; 41 (05) 2255-2257
- 9 Falces-Romero I, Gutiérrez-Arroyo A, Romero-Gómez MP. Catheter-associated bacteremia by Pandoraea pnomenusa in an infant with acute lymphoblastic leukemia. Med Clin (English edition) 2016; 147 (03) 1320
- 10 Johnson LN, Han JY, Moskowitz SM, Burns JL, Qin X, Englund JA. Pandoraea bacteremia in a cystic fibrosis patient with associated systemic illness. Pediatr Infect Dis J 2004; 23 (09) 881-882